LicianPro

PRME stock

Prime Medicine, Inc. Common Stock (PRME) institutional holders · rev $4.6M

Prime Medicine, Inc. Common Stock institutional holders from SEC Form 13F, top 4 by reported value. Each row is the filer's newest 13F for quarters ended 2026-03-31 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Rows marked Prior quarter are filers whose 2026-06-30 13F is not cached yet.

Institutional holders · SEC Form 13F
HolderSharesValueReport
STATE STREET CORP7,576,460$28.0M2026-06-30
FMR LLC1,761,884$6.5M2026-06-30
GOLDMAN SACHS GROUP INC970,425$3.4M2026-03-31Prior quarter
CITADEL ADVISORS LLC336,358$1.2M2026-03-31Prior quarter
These 13F holders as JSON? API free 100/day

PRME institutional holders FAQ

How many PRME 13F holders are listed on this page?

This page lists 2 cached Prime Medicine, Inc. Common Stock (PRME) 13F holders. Holders: https://lician.com/institutional/prme

Who is the largest PRME 13F holder by reported value?

The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/prme/93751. Holders: https://lician.com/institutional/prme

What value and shares did the largest PRME 13F holder report?

STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 7,576,460 shares and a value of $28.0M.

What is the latest PRME 13F report date on this page?

The latest cached 13F report date on this Prime Medicine, Inc. Common Stock (PRME) holders table is Jun 30, 2026.

Which PRME 13F holders report the largest positions?

The largest cached 13F holders by reported value on this Prime Medicine, Inc. Common Stock (PRME) page are STATE STREET CORP and FMR LLC. Holders: https://lician.com/institutional/prme

Where are PRME institutional holders listed?

Cached 13F holders for Prime Medicine, Inc. Common Stock (PRME) are listed at https://lician.com/institutional/prme. Filer directory: https://lician.com/holders

What is PRME's latest revenue?

Latest cached Prime Medicine, Inc. Common Stock (PRME) revenue for Dec 31, 2025 was $4.6M. Statements: https://lician.com/financials/prme

Not investment advice. Figures as filed or reported, not a live feed.